Account Info
Log Out
English
Back
Download
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record delete
    Quotes All >
      News All >
        Log in to access Online Inquiry
        Watchlist
        Loading...
        Dow Jones33762.760+701.190 +2.12%NASDAQ13240.766+139.784 +1.07%S&P 5004282.370+61.350 +1.45%
        US Stock MarketDetailed Quotes
        MRNS Marinus Pharmaceuticals Watchlist
        7.390 +0.170+2.35% Close 06/02 16:00 ET
        7.3900.0000.00% Post 16:01 ET
        7.520High7.145Low633.73KVolume

        Company Profile

        Symbol
        MRNS
        Company Name
        Marinus Pharmaceuticals
        Listing Date
        07/31/2014
        Founded
        2003
        CEO
        Dr. Scott Braunstein, M.D.
        Market
        NASDAQ
        Employees
        153
        Securities Type
        Ordinary Shares
        Fiscal Year Ends
        12-31
        Address
        5 Radnor Corporate Center,100 Matsonford Road,Suite 500
        City
        Radnor
        Province
        Pennsylvania
        Country
        United States of America
        Zip Code
        19087-5279
        Phone
        1-484-801-4670
        Website
        http://www.marinuspharma.com
        Description
        Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.

        Company Executives

        No Data

        Paper Trade Start
        Symbol
        Direction
        Buy
        Sell
        Types
        LMT Order
        Price
        QTY
        Amount
        --
        Buy